Multiple sclerosis characteristics in A frican A merican patients in the New York State Multiple Sclerosis C onsortium

The objective of this study was to determine the clinical characteristics of multiple sclerosis (MS) in A frican A merican (A A) patients in the New York State Multiple Sclerosis C onsortium (NYSMSC) patient registry. The NYSMSC is a group of 18 MS centers throughout New York State organized to pros...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis 2003-06, Vol.9 (3), p.293-298
Hauptverfasser: Weinstock-Guttman, B, Jacobs, L D, Brownscheidle, C M, Baier, M, Rea, D F, Apatoff, B R, Blitz, K M, Coyle, P K, Frontera, A T, Goodman, A D, Gottesman, M H, Herbert, J, Holub, R, Lava, N S, Lenihan, M, Lusins, J, Mihai, C, Miller, A E, Perel, A B, Snyder, D H, Bakshi, R, Granger, C V, Greenberg, S J, Jubelt, B, Krupp, L, Munschauer, F E, Rubin, D, Schwid, S, Smiroldo, J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The objective of this study was to determine the clinical characteristics of multiple sclerosis (MS) in A frican A merican (A A) patients in the New York State Multiple Sclerosis C onsortium (NYSMSC) patient registry. The NYSMSC is a group of 18 MS centers throughout New York State organized to prospectively assess clinical characteristics of MS patients. AA s comprise 6% (329) of the total NYSMSC registrants (5602). Demographics, disease course, therapy, and socioeconomic status were compared in A A registrants versus nonA frican A mericans (NA A). There was an increased female preponderance and a significantly younger age at diagnosis in the AA group. A A patients were more likely to have greater disability with increased disease duration. No differences were seen in types of MS and use of disease modifying therapies. O ur findings suggest a racial influence in MS. Further genetic studies that consider race differences are warranted to elucidate mechanisms of disease susceptibility.
ISSN:1352-4585
1477-0970
DOI:10.1191/1352458503ms909oa